Exodus Point Capital Management, LP Viking Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $11.4 Billion
  • Q2 2025

A detailed history of Exodus Point Capital Management, LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 20,000 shares of VKTX stock, worth $797,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 349,810 94.28%
Holding current value
$797,200
Previous $8.45 Million 93.71%
% of portfolio
0.0%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$19.98 - $29.49 $6.22 Million - $9.17 Million
-311,094 Reduced 88.93%
38,716 $1.03 Million
Q1 2025

May 14, 2025
BUY
$24.15 - $42.89 $2.76 Million - $4.9 Million
114,307 Added 48.54%
349,810 $8.45 Million
Q4 2024

Feb 12, 2025
SELL
$38.28 - $78.03 $1.06 Million - $2.16 Million
-27,656 Reduced 10.51%
235,503 $9.48 Million
Q3 2024

Nov 12, 2024
BUY
$49.84 - $70.47 $10.5 Million - $14.8 Million
210,229 Added 397.18%
263,159 $16.7 Million
Q2 2024

Aug 13, 2024
BUY
$47.39 - $80.2 $1.84 Million - $3.11 Million
38,835 Added 275.52%
52,930 $2.81 Million
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $245,252 - $1.33 Million
14,095 New
14,095 $1.16 Million
Q3 2022

Nov 10, 2022
BUY
$2.55 - $3.89 $16,605 - $25,331
6,512 Added 26.86%
30,753 $84,000
Q2 2022

Aug 19, 2022
BUY
$2.11 - $3.15 $51,148 - $76,359
24,241 New
24,241 $70,000
Q4 2021

Feb 11, 2022
SELL
$4.6 - $6.72 $112,262 - $164,001
-24,405 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$5.58 - $7.04 $285,891 - $360,694
-51,235 Reduced 67.74%
24,405 $153,000
Q2 2021

Aug 16, 2021
BUY
$5.19 - $6.73 $84,892 - $110,082
16,357 Added 27.59%
75,640 $453,000
Q1 2021

May 17, 2021
BUY
$5.74 - $9.67 $340,284 - $573,266
59,283 New
59,283 $375,000
Q3 2020

Nov 16, 2020
SELL
$5.73 - $8.11 $151,667 - $214,663
-26,469 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.35 - $8.08 $115,140 - $213,869
26,469 New
26,469 $191,000
Q1 2020

May 15, 2020
SELL
$3.45 - $7.95 $69,351 - $159,810
-20,102 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$6.38 - $8.73 $98,902 - $135,332
-15,502 Reduced 43.54%
20,102 $161,000
Q3 2019

Nov 14, 2019
BUY
$6.55 - $8.6 $117,677 - $154,507
17,966 Added 101.86%
35,604 $245,000
Q2 2019

Aug 14, 2019
BUY
$7.67 - $10.63 $135,283 - $187,491
17,638 New
17,638 $146,000

Others Institutions Holding VKTX

# of Institutions
448
Shares Held
66.9M
Call Options Held
7.9M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.06B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email